Wiersinga W, Žarković M, Bartalena L, ..., Ayvaz G, Konuk O, Törüner FB, ... EUGOGO. Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism.Eur J Endocrinol. 2018;178(6):635-643.

Kahaly GJ, Riedl M, König J, ... EUGOGO (Collaborator: Ayvaz G, et al.). Mycophenolate plus methylprednisolone versus methylprednisolone alone in active Graves' orbitopathy (MINGO).Lancet Diabetes Endocrinol. 2018;6(4):287-298.

Perros P, Hegedüs L, Bartalena L, ..., Ayvaz G, ... Wiersinga WM. Graves' orbitopathy as a rare disease in Europe: A EUGOGO position statement.Orphanet J Rare Dis. 2017;12:72.

Marso SP, Daniels GH, Brown-Frandsen K, ... LEADER Investigators. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.N Engl J Med. 2016;375(4):311-22.

Bartalena L, Baldeschi L, Boboridis K, ... EUGOGO. The 2016 ETA/EUGOGO Guidelines for the Management of Graves' Orbitopathy.Eur Thyroid J. 2016;5(1):9-26.

Turhan Iyidir O, Konca Degertekin C, Sonmez C, Atak Yucel A, Erdem M, Akturk M, Ayvaz G. The effect of thyroid autoimmunity on T-cell responses in early pregnancy.J Reprod Immunol. 2015;110:61-6.

Perros P, Žarković M, Azzolini C, Ayvaz G, Baldeschi L, Bartalena L, ... PREGO study: changes in referral patterns to EUGOGO centres (2000–2012).Br J Ophthalmol. 2015;99(11):1531-5.

Ayvaz G, Keskin L, Akin F, Dokmetas HS, Tasan E, Ar IB, Uren E; GALATA Study Group. Real-life safety and efficacy of vildagliptin as add-on to metformin in type 2 diabetes — GALATA study.Curr Med Res Opin. 2015;31(4):623-32.

Iyidir OT, Degertekin CK, Yilmaz BA, Altinova AE, Toruner FB, Bozkurt N, Ayvaz G, Akturk M. Serum levels of fetuin A in women with gestational diabetes mellitus.Arch Gynecol Obstet. 2015;291(4):933-7.

Cakir N, Kalan I, Altinova A, ..., Ayvaz G. Continuous subcutaneous insulin infusion therapy and pregnancy outcome in type 1 diabetes.Endocrine Abstracts (2014) 35 P492.

Yalcin MM, Emiroglu T, Ozkan C, Altinova A, Yetkin İ, Karakoc A, Ayvaz G, Arslan M. A lepromatous lepra case presented like diabetic foot.Endocrine Abstracts (2014) 35 P446.

Arslan E, Acik L, Gunaltili G, Ayvaz G, Altinova AE, Arslan M. The effect of calpain-10 gene polymorphism on type 2 diabetes mellitus in a Turkish population.Endokrynol Pol. 2014;65(2):90-5.

Satman I, Omer B, Tutuncu Y, ... TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults.Eur J Epidemiol. 2013;28(2):169-80.

Tan E, Akıncı A, Ayvaz G, Erbaş T, Ertaş M, et al. Irrational drug use in neuropathic pain treatment: a two year data analysis.Int J Medicine and Biomedical Research, Vol 2 No 3 (2013).

Turhan İyidir Ö, Altay M, Konca Degertekin C, Altınova A, Karakoç A, Ayvaz G, Arslan M, et al. Diffuse amyloid deposition in thyroid gland in familial Mediterranean fever.Amyloid. 2012;19(3):161-2.

Porta M, Hainer JW, Jansson SO, ... DIRECT Study Group. Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes.Diabetologia. 2011;54(6):1298-303.

Erbas T, Ertas M, Yucel A, Keskinaslan A, Senocak M; TURNEP Study Group. Prevalence of peripheral neuropathy in Turkish diabetic patients.J Clin Neurophysiol. 2011;28(1):51-5.

Demirci H, Yilmaz M, Ergun MA, Yurtcu E, Bukan N, Ayvaz G. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome.Gynecol Endocrinol. 2010;26(5):348-55.

Yilmaz M, Bukan N, Demirci H, Oztürk C, Kan E, Ayvaz G, Arslan M. Serum resistin and adiponectin levels in women with polycystic ovary syndrome.Gynecol Endocrinol. 2009;25(4):246-52.

Yilmaz M, Yurtçu E, Demirci H, Ergün MA, ..., Ayvaz G, Arslan M. Calpain 10 gene single-nucleotide polymorphism in patients with polycystic ovary syndrome.J Endocrinol Invest. 2009;32(1):13-7.

Rizzo M, Berneis K, Altinova AE, Toruner FB, Akturk M, Ayvaz G, Rini GB, Spinas GA, Arslan M. Atherogenic lipoprotein phenotype and LDL size in women with gestational diabetes.Diabet Med. 2008;25(12):1406-11.

Sjølie AK, Klein R, Porta M, ... DIRECT Programme Study Group. Effect of candesartan on retinopathy in type 2 diabetes (DIRECT-Protect 2).Lancet. 2008;372(9647):1385-93.

Chaturvedi N, Porta M, Klein R, ... DIRECT Programme Study Group. Effect of candesartan on retinopathy in type 1 diabetes (DIRECT-Prevent/Protect 1).Lancet. 2008;372(9647):1394-402.

Toruner F, Altinova AE, Karakoc A, Yetkin I, Ayvaz G, Cakir N, Arslan M. Risk factors for cardiovascular disease in patients with subclinical hypothyroidism.Adv Ther. 2008;25(5):430-7.

Davies M, Lavalle-González F, Storms F, Gomis R; AT.LANTUS Study Group. Initiation of insulin glargine therapy in type 2 diabetes — AT.LANTUS trial.Diabetes Obes Metab. 2008;10(5):387-99.

Altinova AE, Toruner F, Cimen AR, Karakoc A, Atasever T, Yetkin I, Ayvaz G, Cakir N, Arslan M. Neurofibromatosis, bilateral pheochromocytoma and primary hyperparathyroidism.Exp Clin Endocrinol Diabetes. 2007;115(7):468-70.

Altinova AE, Toruner F, Bozkurt N, Bukan N, Karakoc A, Yetkin I, Ayvaz G, Cakir N, Arslan M. Adiponectin and TNF-alpha in gestational diabetes mellitus.Gynecol Endocrinol. 2007;23(3):161-5.

Altinova AE, Toruner F, Karakoc A, Yetkin I, Ayvaz G, Cakir N, Arslan M. Serum ghrelin levels in patients with Hashimoto's thyroiditis.Thyroid. 2006;16(12):1259-64.

Altinova AE, Törüner FB, Aktürk M, Bukan N, Cakir N, Ayvaz G, Arslan M. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.Clin Endocrinol (Oxf). 2006;65(4):530-5.

Yilmaz M, Biri A, Karakoç A, Törüner F, Bingöl B, Cakir N, Tiras B, Ayvaz G, Arslan M. Rosiglitazone and metformin on insulin resistance and serum androgen levels in PKOS.J Endocrinol Invest. 2005;28(11):1003-8.

Yilmaz M, Karakoç A, Törüner FB, Cakir N, Tiras B, Ayvaz G, Arslan M. Rosiglitazone and metformin on menstrual cyclicity and hirsutism in PKOS.Gynecol Endocrinol. 2005;21(3):154-60.

Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Yetkin I, Ayvaz G, Cakir N, Arslan M. Pro12Ala polymorphism of the PPAR-gamma gene in first-degree relatives with PKOS.Gynecol Endocrinol. 2005;21(4):206-10.

Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M. Rosiglitazone and metformin on oxidative stress and homocysteine in lean patients with PKOS.Hum Reprod. 2005;20(12):3333-40.

Yilmaz M, Bukan N, Ersoy R, Karakoç A, Yetkin I, Ayvaz G, Cakir N, Arslan M. Glucose intolerance, insulin resistance and cardiovascular risk in first degree relatives of women with PKOS.Hum Reprod. 2005;20(9):2414-20.

Konuk O, Atasever T, Unal M, Ayvaz G, Yetkin I, Cakir N, Arslan M, Hasanreisoglu B. Orbital gallium-67 scintigraphy as disease activity parameter in Graves' ophthalmopathy.Thyroid. 2005;15(4):358-63.

Karakoc A, Ayvaz G, Taneri F, Toruner F, Yilmaz M, Cakir N, Arslan M. Hypothyroidism in rats and serum leptin concentrations in adipose tissue.Endocr Res. 2004;30(2):247-55.

Törüner F, Akbay E, Cakir N, Sancak B, Elbeg S, Taneri F, Aktürk M, Karakoç A, Ayvaz G, Arslan M. PPARgamma and PPARalpha agonists on serum leptin levels in diet-induced obese rats.Horm Metab Res. 2004;36(4):226-30.

Akbay E, Ulusu NN, Törüner F, Ayvaz G, Taneri F, Aktürk M, Arslan M, Karasu C. Rosiglitazone treatment on the pentose phosphate pathway in liver and kidney of high-fat diet rats.Curr Ther Res Clin Exp. 2004;65(1):79-89.

Kapucu LO, Azizoglu F, Ayvaz G, Karakoc A. Effects of diuretics on iodine uptake in non-toxic goitre.Eur J Nucl Med Mol Imaging. 2003;30(9):1270-2.

Akbay E, Tiras MB, Yetkin I, Törüner F, Ersoy R, Uysal S, Ayvaz G. Insulin secretion and insulin sensitivity in normal pregnancy and gestational diabetes mellitus.Gynecol Endocrinol. 2003;17(2):137-42.

Ayvaz G, Balos Törüner F, Karakoç A, Yetkin I, Cakir N, Arslan M. Acute and chronic effects of free fatty acids on the insulin secreting function of islets.Diabetes Metab. 2002;28(6 Pt 2):3S7-12.

Demirel K, Kapucu O, Yücel C, Ozdemir H, Ayvaz G, Taneri F. Radionuclide thyroid angiography, 99mTc-MIBI scintigraphy and power Doppler ultrasonography in differential diagnosis of cold thyroid nodules.Eur J Nucl Med Mol Imaging. 2003;30(5):642-50.

Konuk O, Atasever T, Unal M, Ayvaz G, Yetkin I, Cakir N, Arslan M, Hasanreisoglu B. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.Thyroid. 2002;12(7):603-8.

Sancak A, Karakoc A, Yetkin I, Ayvaz G, Cakir N, Aslan M. Antineutrophil cytoplasmic autoantibody associated vasculitis presenting with hashitoxicosis.Nephron. 2000;86(3):368-9.

Ayvaz G, Sener A, Malaisse WJ. Effects of extracellular pH upon the insulinotropic action of alpha-D-glucose pentaacetate.Res Commun Mol Pathol Pharmacol. 1999;103(1):83-90.

Yetkin I, Ayvaz G, Arslan M, Yilmaz M, Cakir N. A case of Costello syndrome with endocrine features.Ann Genet. 1998;41(3):157-60.

Törüner FB, Konuk O, Ayvaz G. "Combined Thyroid-Eye Clinics". In: Wiersinga WM, Kahaly GJ (Eds). Graves' Orbitopathy: A Multidisciplinary Approach — Questions and Answers.Basel, Karger, 2017, pp: 113-118.

von Arx G, Ayvaz G. "The Patient's View". In: Wiersinga WM, Kahaly GJ (Eds). Graves' Orbitopathy: A Multidisciplinary Approach — Questions and Answers.Basel, Karger, 2017, pp: 285-290.